RNA vs WDAY · rev $22.6M vs P/E 135, rev $5.19B
Atrium Therapeutics, Inc. Common Stock (RNA) versus Workday Inc (WDAY) — a side-by-side from cached financials, not a winner call.
Atrium Therapeutics, Inc. Common Stock (RNA) is a biotechnology company listed on NASDAQ.
Workday Inc (WDAY) is a software - application company listed on US.
Latest reported RNA revenue for 2026-06-30 was $22.6M. Net income was -$36.8M. Revenue was up 15.3% from 2026-03-31 to 2026-06-30. RNA currently screens at market cap $217.5M.
Latest reported WDAY revenue for 2026-07-31 was $5.19B. Net income was $854.0M. WDAY currently screens at market cap $64.45B and trailing P/E 135.1.
RNA currently screens at market cap $217.5M. WDAY currently screens at market cap $64.45B and trailing P/E 135.1.
Not investment advice. Open the RNA and WDAY stock pages for the full models.
Not investment advice.